BMSEED: News
BMSEED is committed to driving innovation and creating a positive impact on the biomedical research community. Our mission is to develop and provide state-of-the-art devices that empower researchers, biomedical scientists, and healthcare professionals to push the boundaries of scientific discovery. Through our cutting-edge technologies, including stretchable microelectrode arrays and advanced cell-stretching systems, we aim to facilitate more effective and efficient biomedical studies. Our focus is on supporting the advancement of biomedical science, fostering collaboration, and enabling groundbreaking research that can transform healthcare. Whether through partnerships, product innovation, or knowledge sharing, BMSEED is dedicated to shaping the future of biomedicine.
Reach Out to BMSEED
Contact us at BMSEED if you're interested in the MEASSuRE system. Our team will walk you through how this tool can support and enhance your research.
BMSEED Accepted as Finalist in 2017 Venture Madness
BMSEED was selected by Invest Southwest to be among the Top 64 startup companies in the 2017 Venture Madness competition.
BMSEED Named One of the Top 500 Startups Worldwide
BMSEED was selected as one of the Top 500 startups worldwide by the 2016 Hello Tomorrow Challenge.
BMSEED Awarded $568,982 Phase I SBIR from NINDS
BMSEED received a Phase I SBIR from NINDS to develop a novel electrode array for electrocorticography to improve brain-machine interfaces and outcomes of epilepsy surgeries ($568,982).